Virtu Financial LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 83 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$17
+21.4%
13,098
-59.6%
0.00%
+100.0%
Q1 2023$14
-99.9%
32,386
+118.6%
0.00%0.0%
Q3 2022$11,000
-93.5%
14,812
-33.9%
0.00%
-92.3%
Q3 2019$170,000
+40.5%
22,425
+0.2%
0.01%
+85.7%
Q1 2019$121,000
+202.5%
22,384
+66.9%
0.01%
+250.0%
Q4 2018$40,00013,4140.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders